ACQUINET
Live / Allowed — Notice of allowance issued (as of 16 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99106752
- Mark type
- Stylized text
- Filed
- 27 Mar 2025
- Published for opposition
- 21 Oct 2025
- Attorney of record
- Julia Anne Matheson
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof for use in connection with medical ultrasound apparatus to facilitate the lowering of the blood brain barrier; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof for use in connection with medical ultrasound apparatus to facilitate the disruption of the blood brain barrier; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof for use in connection with medical ultrasound apparatus to increase the permeability of the blood brain barrier; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof to be used in connection with ultrasound apparatus for therapeutic and diagnostic medical procedures in the fields of neurology, oncology, gynecology and urology; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof to be used in connection with ultrasound apparatus for therapeutic and diagnostic medical procedures with respect to central nervous system disorders, neurodegenerative disease, neuro-oncological disease, neuropsychiatric and behavioral disorders, movement disorders, prostate cancer, uterine fibroids and bone metastases; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof to be used in connection with ultrasound apparatus for therapeutic and diagnostic medical procedures, namely, for use in the ablation of tissue, sonication of tissue, and disruption of the blood brain barrier
Owner
- Insightec Ltd., Tirat Carmel, IL
- Insightec Ltd., Tirat Carmel, IL
Prosecution history
- 16 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Oct 2025 — PUBLISHED FOR OPPOSITION
- 15 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Sept 2025 — EXAMINER'S AMENDMENT ENTERED
- 24 Sept 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 24 Sept 2025 — EXAMINERS AMENDMENT E-MAILED
- 24 Sept 2025 — EXAMINERS AMENDMENT -WRITTEN
- 26 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Aug 2025 — NON-FINAL ACTION E-MAILED
- 26 Aug 2025 — NON-FINAL ACTION WRITTEN
- 26 Aug 2025 — ASSIGNED TO EXAMINER
- 11 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Mar 2025 — APPLICATION FILING RECEIPT MAILED